Editorial: Co-morbidity of COVID 19 and fungal infections.

Pandey, Ramendra Pati; Dhiman, Ruby; Mishra, Vivek; Raj, V Samuel; Chang, Chung-Ming

Pandey, Ramendra Pati; Dhiman, Ruby; Mishra, Vivek; Raj, V Samuel; Chang, Chung-Ming.

Afiliação

Pandey RP; School of Health Sciences and Technology (SoHST), UPES, Dehradun, Uttarakhand, India.
Dhiman R; School of Health Sciences and Technology (SoHST), UPES, Dehradun, Uttarakhand, India.
Mishra V; Amity Institute of Click-Chemistry Research and Studies (AICCRS), Amity University Uttar Pradesh, Noida, India.
Raj VS; Centre for Drug Design Discovery and Development (C4D), SRM University, Sonepat, Haryana, India.
Chang CM; Master & Ph.D. Program in Biotechnology Industry, Chang Gung University, Taoyuan, Taiwan.

Front Fungal Biol ; 5: 1462172, 2024.

Article em En | MEDLINE | ID: mdl-39351259

Palavras-chave

COVID-19; clinical management; co-morbidity; fungal infections; morbidity and mortality

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Fungal Biol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google